Noveltreat 2.4 mg Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Noveltreat 2.4 mg from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Noveltreat 2.4 mg Know its uses, benefits , Side effects, and storage details.
Noveltreat 2.4 mg is a pre-filled injection containing semaglutide, used for managing type 2 diabetes and chronic weight control. It is injected under the skin in the abdomen, thigh, or upper arm once a week as directed by a doctor.
Uses :
Manages high blood sugar levels in adults with type 2 diabetes.
Helps with long-term weight reduction and weight management alongside a low-calorie diet and exercise.
Common Side Effects :
Nausea and vomiting
Diarrhea or constipation
Stomach pain and bloating
Reduced appetite and tiredness
Headache.
Serious Side Effects (Seek Medical Help) :
Severe, ongoing abdominal pain radiating to the back (sign of pancreatitis)
Yellowing of skin or eyes, upper right stomach pain (gallbladder issues
Severe allergic reactions (swelling of the face, lips, or throat).
Storage Instructions :
Keep unopened pens in a refrigerator between 2°C and 8°C.Do not freeze.
Once you start using the pen, it can be kept at room temperature (below 30°C) or in the fridge for up to 6 weeks.
Keep the pen cap on when not in use to protect it from light.
Precautions :
Medical History: Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Conditions to Report: Inform your doctor if you have had pancreatitis, kidney disease, liver problems, gallbladder issues, or diabetic eye disease.
Pregnancy & Breastfeeding: Not recommended during pregnancy or while breastfeeding; stop use well in advance if planning a pregnancy.
Drug Interactions: Use with caution alongside insulin or sulfonylureas due to a higher risk of low blood sugar (hypoglycemia).
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
City Drug Exporters specializes in exporting Noveltreat 2.4 mg from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Noveltreat 2.4 mg Know its uses, benefits , Side effects, and storage details.
Noveltreat 2.4 mg is a pre-filled injection containing semaglutide, used for managing type 2 diabetes and chronic weight control. It is injected under the skin in the abdomen, thigh, or upper arm once a week as directed by a doctor.
Uses :
Manages high blood sugar levels in adults with type 2 diabetes.
Helps with long-term weight reduction and weight management alongside a low-calorie diet and exercise.
Common Side Effects :
Nausea and vomiting
Diarrhea or constipation
Stomach pain and bloating
Reduced appetite and tiredness
Headache.
Serious Side Effects (Seek Medical Help) :
Severe, ongoing abdominal pain radiating to the back (sign of pancreatitis)
Yellowing of skin or eyes, upper right stomach pain (gallbladder issues
Severe allergic reactions (swelling of the face, lips, or throat).
Storage Instructions :
Keep unopened pens in a refrigerator between 2°C and 8°C.Do not freeze.
Once you start using the pen, it can be kept at room temperature (below 30°C) or in the fridge for up to 6 weeks.
Keep the pen cap on when not in use to protect it from light.
Precautions :
Medical History: Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Conditions to Report: Inform your doctor if you have had pancreatitis, kidney disease, liver problems, gallbladder issues, or diabetic eye disease.
Pregnancy & Breastfeeding: Not recommended during pregnancy or while breastfeeding; stop use well in advance if planning a pregnancy.
Drug Interactions: Use with caution alongside insulin or sulfonylureas due to a higher risk of low blood sugar (hypoglycemia).
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
Keywords
